Efectos de la vitamina D sérico y suplemento en pacientes infectados por la COVID-19

Henry Mejía-Zambrano

doi:10.35839/repis.6.1.1141

Authors

Henry Mejía-Zambrano Universidad Privada San Juan Bautista. Lima, Perú https://orcid.org/0000-0001-7325-7796

DOI:

https://doi.org/10.35839/repis.6.1.1141

Keywords:

SARS-CoV-2, COVID-19, vitamin D

Abstract

Background: The COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2, which appeared in late 2019 in Hubei province, Wuhan region of the People's Republic of China. Objective: To determine the effects of serum vitamin D and supplement in patients infected with COVID-19. Methods: Experimental and observational studies were included in this systemic review; studies on the effects of serum vitamin D and supplement in patients with COVID-19; studies with available text and studies in the English and Spanish language were included. A formal narrative synthesis of the collected data was carried out, no formal statistical synthesis was carried out. The methodological quality of the articles was evaluated using the quality assessment tools of the National Heart, Lung and Blood Institute (NHLBI). Results: Seropositivity in patients with SARS-CoV-2 was not associated with vitamin D3 deficiency (OR=0.99; 95% CI=0.85-1.16). The difference between the vitamin D3 group and the placebo group was not significant for hospital mortality (7.6% versus 5.1%; [95% CI= -4.1% to 9.2%]. Admission to the intensive care unit (16.0% vs 21.2%; [95% CI= -15.1% to 4.7%]; respectively. Conclusion: Vitamin D deficiency causes increased hospitalization and severity in patients infected with COVID-19. In addition, vitamin D administration does not appear to produce beneficial or adverse events. More randomised clinical trials are needed.

Downloads

Download data is not yet available.

References

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik Y, et al. Coronavirus disease 2019–COVID-19. Clinical Microbiology Reviews [Internet]. 2020 [citado el 19/07/2021]; 33(4): 1-48. Disponible: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405836/

Organización Mundial de la Salud. Tablero COVID-19 [Internet]. Organización Mundial de la Salud; [citado el 19/07/2021]. Disponible: https://covid19.who.int/

DeLuca HF. Overview of general physiologic features and functions of vitamin D. The American journal of clinical nutrition [Internet]. 2004 [citado el 19/07/2021]; 80(6). Disponible: https://pubmed.ncbi.nlm.nih.gov/15585789/

Beard HA, Bearden A, Striker R. Vitamin D and the anti-viral state. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [Internet]. 2011 [citado el 19/07/2021]; 50(3): 194-200. Disponible: https://pubmed.ncbi.nlm.nih.gov/21242105/

Jiménez-Sousa M, Martínez I, Medrano L, Fernández-Rodríguez A, Resino S. Vitamin D in human immunodeficiency virus infection: Influence on immunity and disease. Frontiers in Immunology [Internet]. 2018 [citado el 19/07/2021]; 9(3). Disponible: https://pubmed.ncbi.nlm.nih.gov/29593721/

Hansdottir S, Monick MM. Vitamin D effects on lung immunity and respiratory diseases. Vitamins and hormones [Internet]. 2011 [citado el 19/07/2021]; 86: 217-237. Disponible: https://pubmed.ncbi.nlm.nih.gov/21419273/

Zu Z, Di Jiang M, Xu P, Chen W, Ni Q, Lu G, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology [Internet]. 2020 [citado el 19/07/2021]; 296(2): 15-25. Disponible: https://pubmed.ncbi.nlm.nih.gov/32083985/

Martín Giménez V, Inserra F, Tajer C, Mariani J, Ferder L, Reiter R, et al. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sciences [Internet]. 2020 [citado el 19/07/2021]; 254. Disponible: https://pubmed.ncbi.nlm.nih.gov/32422305/

Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients [Internet]. 2020 [citado el 19/07/2021]; 12(5): 1466. Disponible: https://pubmed.ncbi.nlm.nih.gov/32438620/

Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. Journal of Infection [Internet]. 2020 [citado el 19/07/2021]; 80(6): 639-645. Disponible: https://pubmed.ncbi.nlm.nih.gov/32240670/

Entrenas Castillo M, Entrenas Costa L, Vaquero Barrios J, Alcalá Díaz J, López Miranda J, Bouillon R, et al. “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”. Journal of Steroid Biochemistry and Molecular Biology [Internet]. 2020 [citado el 19/07/2021]; 203. Disponible: https://pubmed.ncbi.nlm.nih.gov/32871238/

D'Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, et al. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients [Internet]. 2020 [citado el 19/07/2021]; 12(5). Disponible: https://pubmed.ncbi.nlm.nih.gov/32397511/

Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clinical endocrinology [Internet]. 2020 [citado el 19/07/2021]; 93(4): 508-511. Disponible: https://pubmed.ncbi.nlm.nih.gov/32621392/

Urrutia G, Bonfill X. Declaracion PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. MEDICINA CLINICA [Internet]. 2010 [citado el 19/07/2021]; 135(11): 507-511. Disponible: https://es.cochrane.org/sites/es.cochrane.org/files/public/uploads/PRISMA_Spanish.pdf

Instituto Nacional del Corazón, los Pulmones y la Sangre. Herramienta de evaluación de la calidad para estudios observacionales de cohortes y transversales [Internet]. Instituto Nacional del Corazón, los Pulmones y la Sangre; [citado el 19/07/2021]. Disponible en: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.

Lakkireddy M, Gadiga S, Malathi R, Karra M, Raju I, Chinapaka S, et al. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Scientific Reports [Internet]. 2021 [citado el 19/07/2021]; 11(1): 10641. Disponible: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138022/

Tan C, Ho LP, Kalimuddin S, Cherng B, Teh Y, Thien SY, et al. Cohort study to evaluate effect of vitamin D, magnesium, and vitamin B12 in combination on severe outcome progression in older patients with coronavirus (COVID-19). Nutrition [Internet]. 2020 [citado el 19/07/2021]; 79-80(80): 111017. Disponible: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832811/

Ling S, Broad E, Murphy R, Pappachan J, Pardesi-Newton S, Kong M, et al. High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with covid-19: A cross-sectional multi-centre observational study. Nutrients [Internet]. 2020 [citado el 19/07/2021]; 12(12): 1-16. Disponible: https://pubmed.ncbi.nlm.nih.gov/33322317/

Sulli A, Gotelli E, Casabella A, Paolino S, Pizzorni C, Alessandri E, et al. Vitamin d and lung outcomes in elderly covid-19 patients. Nutrients [Internet]. 2021 [citado el 19/07/2021]; 13(3): 1-13. Disponible: https://pubmed.ncbi.nlm.nih.gov/33668240/

Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, Martin-Escalante MD, Cortes-Rodriguez B, Zambrana-Garcia JL, et al. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study. Nutrients [Internet]. 2021 [citado el 19/07/2021]; 13(6): 1760. Disponible: https://pubmed.ncbi.nlm.nih.gov/34064175/

Campi I, Gennari L, Merlotti D, Mingiano C, Frosali A, Giovanelli L, et al. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infectious Diseases [Internet]. 2021 [citado el 19/07/2021]; 21(1): 566. Disponible: https://pubmed.ncbi.nlm.nih.gov/34126960/

De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA. Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality. American journal of clinical pathology [Internet]. 2021 [citado el 19/07/2021]; 155(3): 381-388. Disponible: https://pubmed.ncbi.nlm.nih.gov/33236114/

Li Y, Tong C, Bare L, Devlin J. Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults. JAMA Network Open [Internet]. 2021 [citado el 19/07/2021]; 4(5): e2111634. Disponible: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779952

Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, et al. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA [Internet]. 2021 [citado el 19/07/2021]; 325(11): 1053-1060. Disponible: https://jamanetwork.com/journals/jama/fullarticle/2776738

Oristrell J, Oliva J, Casado E, Subirana I, Domínguez D, Toloba A, et al. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. Journal of Endocrinological Investigation [Internet]. 2021 [citado el 19/07/2021]: 1-13. Disponible: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285728/

Meltzer D, Best T, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Network Open [Internet]. 2020 [citado el 19/07/2021]; 3(9): e2019722-e2019722. Disponible: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770157

Sabico S, Enani M, Sheshah E, Aljohani N, Aldisi D, Alotaibi N, et al. Effects of a 2-week 5000 iu versus 1000 iu vitamin d3 supplementation on recovery of symptoms in patients with mild to moderate covid-19: A randomized clinical trial. Nutrients [Internet]. 2021 [citado el 19/07/2021]; 13(7): 2170. Disponible: https://pubmed.ncbi.nlm.nih.gov/34202578/